Cripto-1: An embryonic gene that promotes tumorigenesis

Nadia Pereira De Castro, Maria Cristina Rangel, Tadahiro Nagaoka, David S. Salomon, Caterina Bianco

Research output: Contribution to journalReview article

36 Citations (Scopus)

Abstract

Several studies have shown that cell fate regulation during embryonic development and oncogenic transformation share common regulatory mechanisms and signaling pathways. Indeed, an embryonic gene member of the EGF-Cripto-1/FRL1/ Cryptic family, Cripto-1, has been implicated in embryogenesis and in carcinogenesis. Cripto-1 together with the TGF- ligand Nodal is a key regulator of embryonic development and is a marker of undifferentiated human and mouse embryonic stem cells. While Cripto-1 expression is very low in normal adult tissues, Cripto-1 is re-expressed at high levels in several different human tumors, modulating cancer cell proliferation, migration, epithelial-to- mesenchymal transition and stimulating tumor angiogenesis. Therefore, inhibition of Cripto-1 expression using blocking antibodies or antisense expression vectors might be a useful modality not only to target fully differentiated cancer cells but also to target a subpopulation of tumor cells with stem-like characteristics.

Original languageEnglish
Pages (from-to)1127-1142
Number of pages16
JournalFuture Oncology
Volume6
Issue number7
DOIs
Publication statusPublished - 01-07-2010
Externally publishedYes

Fingerprint

Carcinogenesis
Embryonic Development
Genes
Neoplasms
Blocking Antibodies
Epithelial-Mesenchymal Transition
Neoplastic Stem Cells
Epidermal Growth Factor
Cell Movement
Cell Proliferation
Ligands

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

De Castro, N. P., Rangel, M. C., Nagaoka, T., Salomon, D. S., & Bianco, C. (2010). Cripto-1: An embryonic gene that promotes tumorigenesis. Future Oncology, 6(7), 1127-1142. https://doi.org/10.2217/fon.10.68
De Castro, Nadia Pereira ; Rangel, Maria Cristina ; Nagaoka, Tadahiro ; Salomon, David S. ; Bianco, Caterina. / Cripto-1 : An embryonic gene that promotes tumorigenesis. In: Future Oncology. 2010 ; Vol. 6, No. 7. pp. 1127-1142.
@article{ede9ed7dfbb24b7d8ea12523e9d72a7c,
title = "Cripto-1: An embryonic gene that promotes tumorigenesis",
abstract = "Several studies have shown that cell fate regulation during embryonic development and oncogenic transformation share common regulatory mechanisms and signaling pathways. Indeed, an embryonic gene member of the EGF-Cripto-1/FRL1/ Cryptic family, Cripto-1, has been implicated in embryogenesis and in carcinogenesis. Cripto-1 together with the TGF- ligand Nodal is a key regulator of embryonic development and is a marker of undifferentiated human and mouse embryonic stem cells. While Cripto-1 expression is very low in normal adult tissues, Cripto-1 is re-expressed at high levels in several different human tumors, modulating cancer cell proliferation, migration, epithelial-to- mesenchymal transition and stimulating tumor angiogenesis. Therefore, inhibition of Cripto-1 expression using blocking antibodies or antisense expression vectors might be a useful modality not only to target fully differentiated cancer cells but also to target a subpopulation of tumor cells with stem-like characteristics.",
author = "{De Castro}, {Nadia Pereira} and Rangel, {Maria Cristina} and Tadahiro Nagaoka and Salomon, {David S.} and Caterina Bianco",
year = "2010",
month = "7",
day = "1",
doi = "10.2217/fon.10.68",
language = "English",
volume = "6",
pages = "1127--1142",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "7",

}

De Castro, NP, Rangel, MC, Nagaoka, T, Salomon, DS & Bianco, C 2010, 'Cripto-1: An embryonic gene that promotes tumorigenesis', Future Oncology, vol. 6, no. 7, pp. 1127-1142. https://doi.org/10.2217/fon.10.68

Cripto-1 : An embryonic gene that promotes tumorigenesis. / De Castro, Nadia Pereira; Rangel, Maria Cristina; Nagaoka, Tadahiro; Salomon, David S.; Bianco, Caterina.

In: Future Oncology, Vol. 6, No. 7, 01.07.2010, p. 1127-1142.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Cripto-1

T2 - An embryonic gene that promotes tumorigenesis

AU - De Castro, Nadia Pereira

AU - Rangel, Maria Cristina

AU - Nagaoka, Tadahiro

AU - Salomon, David S.

AU - Bianco, Caterina

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Several studies have shown that cell fate regulation during embryonic development and oncogenic transformation share common regulatory mechanisms and signaling pathways. Indeed, an embryonic gene member of the EGF-Cripto-1/FRL1/ Cryptic family, Cripto-1, has been implicated in embryogenesis and in carcinogenesis. Cripto-1 together with the TGF- ligand Nodal is a key regulator of embryonic development and is a marker of undifferentiated human and mouse embryonic stem cells. While Cripto-1 expression is very low in normal adult tissues, Cripto-1 is re-expressed at high levels in several different human tumors, modulating cancer cell proliferation, migration, epithelial-to- mesenchymal transition and stimulating tumor angiogenesis. Therefore, inhibition of Cripto-1 expression using blocking antibodies or antisense expression vectors might be a useful modality not only to target fully differentiated cancer cells but also to target a subpopulation of tumor cells with stem-like characteristics.

AB - Several studies have shown that cell fate regulation during embryonic development and oncogenic transformation share common regulatory mechanisms and signaling pathways. Indeed, an embryonic gene member of the EGF-Cripto-1/FRL1/ Cryptic family, Cripto-1, has been implicated in embryogenesis and in carcinogenesis. Cripto-1 together with the TGF- ligand Nodal is a key regulator of embryonic development and is a marker of undifferentiated human and mouse embryonic stem cells. While Cripto-1 expression is very low in normal adult tissues, Cripto-1 is re-expressed at high levels in several different human tumors, modulating cancer cell proliferation, migration, epithelial-to- mesenchymal transition and stimulating tumor angiogenesis. Therefore, inhibition of Cripto-1 expression using blocking antibodies or antisense expression vectors might be a useful modality not only to target fully differentiated cancer cells but also to target a subpopulation of tumor cells with stem-like characteristics.

UR - http://www.scopus.com/inward/record.url?scp=77954677991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954677991&partnerID=8YFLogxK

U2 - 10.2217/fon.10.68

DO - 10.2217/fon.10.68

M3 - Review article

C2 - 20624125

AN - SCOPUS:77954677991

VL - 6

SP - 1127

EP - 1142

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 7

ER -

De Castro NP, Rangel MC, Nagaoka T, Salomon DS, Bianco C. Cripto-1: An embryonic gene that promotes tumorigenesis. Future Oncology. 2010 Jul 1;6(7):1127-1142. https://doi.org/10.2217/fon.10.68